GENERAL16 Sept 2026
Centre plans ban on import, sale of two antibiotics for animal use in India
India has moved to ban the import and sale of two antibiotics used in animals. A draft notification covers carboxypenicillins and phosphonic acid derivatives. The aim is to tighten antimicrobial-use rules and curb drug resistance. This affects animal medicine makers, vets and farmers. If you sell or use these products, review the draft and plan safer alternatives early.
Key Statutory Highlights
- A draft notification seeks to prohibit carboxypenicillins and phosphonic acid derivatives in animals.
- India is tightening antimicrobial-use rules to curb drug resistance.
- The proposed ban covers the import and sale of these two antibiotics for animal use in India.
Actionable Advice for Taxpayers / Founders:If your business makes, sells or uses animal antibiotics, read the draft notification and speak to your supplier or a compliance advisor about possible substitutes, since a draft does not mean the ban is final yet.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: